Literature DB >> 3064874

Absence of mutation in the beta-amyloid cDNAs cloned from the brains of three patients with sporadic Alzheimer's disease.

M P Vitek1, C G Rasool, F de Sauvage, S M Vitek, R T Bartus, B Beer, R A Ashton, A F Macq, J M Maloteaux, A J Blume.   

Abstract

Using an oligonucleotide probe, we isolated cDNA clones corresponding to the precursor of the beta-amyloid peptide (BAP) from brain libraries of 3 patients with sporadic Alzheimer's disease (AD). DNA sequencing showed that the largest cDNA clone encompasses 83% of the open reading frame proposed by Kang et al. to encode the BAP precursor (APP). cDNA clones from each of the 3 AD brain libraries were identical to the sequence of the APP-cDNAs cloned from normal adult human and fetal brain. An antisense-radiolabeled RNA copy of one of the AD clones detected a pattern of 3 gene transcripts measuring 3.5, 3.2 and 1.6 kilobases (kb) in both normal and AD brain RNAs. These data suggest that there are no mutations in or about the 42 amino acid (aa) sequence of BAP and that the accumulation of amyloid consistently found in AD may result from altered post-translational processing of APP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064874     DOI: 10.1016/0169-328x(88)90004-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

2.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

Authors:  D Goldgaber; H W Harris; T Hla; T Maciag; R J Donnelly; J S Jacobsen; M P Vitek; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Tau is essential to beta -amyloid-induced neurotoxicity.

Authors:  Mark Rapoport; Hana N Dawson; Lester I Binder; Michael P Vitek; Adriana Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 4.  Molecular and cellular biology of Alzheimer amyloid.

Authors:  C A Marotta; R E Majocha; B Tate
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

5.  Arginine specific endopeptidases modify the aggregation properties of a synthetic peptide derived from Alzheimer beta/A4 amyloid.

Authors:  T Honda; C A Marotta
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

6.  Alternative polyadenylation of the amyloid protein precursor mRNA regulates translation.

Authors:  F de Sauvage; V Kruys; O Marinx; G Huez; J N Octave
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

7.  Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.

Authors:  F Tagliavini; F Prelli; J Ghiso; O Bugiani; D Serban; S B Prusiner; M R Farlow; B Ghetti; B Frangione
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

8.  Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease.

Authors:  Gaël Nicolas; Rocío Acuña-Hidalgo; Michael J Keogh; Olivier Quenez; Marloes Steehouwer; Stefan Lelieveld; Stéphane Rousseau; Anne-Claire Richard; Manon S Oud; Florent Marguet; Annie Laquerrière; Chris M Morris; Johannes Attems; Colin Smith; Olaf Ansorge; Safa Al Sarraj; Thierry Frebourg; Dominique Campion; Didier Hannequin; David Wallon; Christian Gilissen; Patrick F Chinnery; Joris A Veltman; Alexander Hoischen
Journal:  Alzheimers Dement       Date:  2018-08-13       Impact factor: 21.566

Review 9.  The role of de novo mutations in adult-onset neurodegenerative disorders.

Authors:  Gaël Nicolas; Joris A Veltman
Journal:  Acta Neuropathol       Date:  2018-11-26       Impact factor: 17.088

10.  Regulatory region of human amyloid precursor protein (APP) gene promotes neuron-specific gene expression in the CNS of transgenic mice.

Authors:  D O Wirak; R Bayney; C A Kundel; A Lee; G A Scangos; B D Trapp; A J Unterbeck
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.